Candace Cameron Bure Provides Update on Dave Coulier's Health During His Cancer Battle
February 9, 2025 - 00:26
In a heartfelt conversation at the 32nd Annual Movieguide Awards, Candace Cameron Bure shared insights about her longtime friend and 'Full House' co-star, Dave Coulier. She revealed that she frequently reaches out to Coulier, who is currently undergoing treatment for stage 3 non-Hodgkin lymphoma, a diagnosis he received in October 2024.
Bure expressed her admiration for Coulier's resilience during this challenging time, emphasizing that he remains optimistic and strong as he navigates his recovery journey. The support from friends and family has been crucial for Coulier, and Bure's regular check-ins serve as a reminder of their enduring bond.
As fans continue to rally behind him, Bure's updates bring a sense of hope and solidarity. The entertainment community stands united in sending positive thoughts and prayers for Coulier's health and well-being as he fights this battle with courage and determination.
MORE NEWS
August 12, 2026 - 11:33
Russia releases former US Marine reported in poor healthA former United States Marine who had been held in Russia since 2022 has been released, according to reports on Tuesday. The man, identified as Robert Gilman, was detained on charges that have not...
August 11, 2026 - 22:47
NYC Health + Hospitals/Carter Appoints New Chief Nursing OfficerNYC Health + Hospitals announced today that Caroline H. Araullo has been appointed as the new Chief Nursing Officer at NYC Health + Hospitals/Carter. Araullo brings a strong background in nursing...
August 11, 2026 - 10:31
Should You Try Ube?Ube, the vivid purple yam native to the Philippines, has moved from trendy desserts like ube cheesecake and ice cream into the mainstream spotlight. But beyond its striking color, this root...
August 10, 2026 - 19:06
Trump returns to controversial vaccine policy with order questioning childhood scheduleThe White House is wading back into the vaccine debate, this time with an executive order that questions the standard childhood immunization schedule. The move marks a shift for the administration,...